NetworkNewsBreaks

WednesdayJul 10, 2019 3:14 pm

NetworkNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Obtains Lucrative, Multiyear Hemp Purchase Order

Green Hygienics Holdings (OTCQB: GRYN), a full-scope, science-driven, premium-cannabis cultivation and branding enterprise, recently entered a multiyear purchase order for the sale of hemp to U.S. Tobacco de Mexico (http://nnw.fm/mKA8N). An article discussing the company reads, “The lucrative five-year contract will require Green Hygienics to deliver $56.4 million worth of hemp flower to the Tijuana, Mexico-based firm for use in its production lines. . . . U.S. Tobacco de Mexico is a Tijuana-based tobacco and cigarette product importer. Its excellent management team and global positioning capabilities will provide various opportunities, making the partnership an exciting one, Green Hygienics Vice President of…

Continue Reading

WednesdayJul 10, 2019 3:00 pm

NetworkNewsBreaks – Earth Science Tech Inc. (ETST) Subsidiary Advancing Women’s Wellbeing

Florida-based biotechnology company Earth Science Tech (OTCQB: ETST), through its wholly owned subsidiaries, is focused on helping women by providing ways to assess and treat sexually transmitted infections (“STI”). A recent article discussing the company reads, “Subsidiary Earth Science Pharmaceutical is committed to bringing low-cost, noninvasive testing processes and vaccines for sexually transmitted infections to market to help women improve the quality of their lives. The company’s first medical device, Hygee, is a home kit designed as a modified panty liner to allow for the self-collection of a gynecological specimen that can be tested for two types of infections —…

Continue Reading

WednesdayJul 10, 2019 2:15 pm

NetworkNewsBreaks – Why Willow Biosciences Inc. (CSE: WLLW) Is ‘One to Watch’

Alberta, Canada-based Willow Biosciences (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. A recent article discussing Willow Biosciences reads, “The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by chief scientific…

Continue Reading

WednesdayJul 10, 2019 2:08 pm

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Primed for Profit as Industrial Hemp Sector Rapidly Expands

Sugarmade (OTCQB: SGMD), a major supplier to the growing hydroponic cultivation sector, is poised to benefit as the industrial hemp sector is forecasted to reach $13.03 billion by 2026 from $4.63 billion in 2018, increasing at a CAGR of 13.7% (http://nnw.fm/M1qBs). An article discussing the company reads, “There are several reasons why this market is forecast to expand at such a rapid rate. Hemp is a highly versatile plant that can be cultivated as a renewable source for raw materials utilized by various industries. In addition, hemp is a very lucrative rotation crop due to its ability to detoxify the soil…

Continue Reading

WednesdayJul 10, 2019 11:25 am

NetworkNewsBreaks – Spectrum Global Solutions, Inc. (SGSI) Announces Decision to Terminate Definitive Share Purchase Agreement with WaveTech Global

Leading telecommunications engineering and infrastructure services provider Spectrum Global Solutions (OTCQB: SGSI) today announced its decision to terminate the company’s definitive share purchase agreement with WaveTech Global, Inc. According to the update, Spectrum’s decision is due to a failure of certain representations, warranties and conditions set forth in the agreement. “Attempting to be a disciplined acquirer and having already completed a number of successful acquisitions, with the failure of certain material representations and conditions we simply felt it was in the best interest of our shareholders to not move forward with the agreement at the present time,” Spectrum Global Solutions…

Continue Reading

WednesdayJul 10, 2019 10:52 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Partners with Nic’s Beverages in Definitive CBD Beverage License Agreement

Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced its entry into a definitive 5-year agreement, via its subsidiary Lexaria Hemp Corp, with Nic’s Beverages L.L.C. Under the agreement, Lexaria will provide its patented DehydraTECH(TM) technology for use in Nic’s CBD-based beverages to be produced and sold throughout the United States. According to the update, Nic’s Beverages will initially begin production of ready-to-drink cold brew coffees enhanced with CBD from multi spectrum hemp oil. “We are currently in discussions with major wholesale houses and are looking to be in the market by the…

Continue Reading

WednesdayJul 10, 2019 10:42 am

NetworkNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces Portfolio Company’s Receipt of Five New AGLC Cannabis Retail Licenses

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Tuesday announced that its portfolio company, YSS Corp. (TSXV: YSS) (WKN: A2PMAX), has received five cannabis retail licenses from the Alberta Gaming, Liquor and Cannabis Commission ("AGLC"). Per the update, the five new licenses will operate under the YSS(TM) brand name and are located throughout Alberta. “YSS has made tremendous progress building up their retail presence in Alberta – doubling their current AGLC licensed stores to ten,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “With plans to have all ten stores open by the end of August, this…

Continue Reading

WednesdayJul 10, 2019 9:41 am

NetworkNewsBreaks – MustGrow Biologics Corp (CSE: MGRO) Commences Trading on the Canadian Securities Exchange

MustGrow Biologics (CSE: MGRO), an agricultural biotech company, this morning announced that its common shares will commence trading today under the ticker symbol "MGRO" on the Canadian Securities Exchange. According to the update, full details are set out in MustGrow’s final prospectus, dated June 20, 2019, with a copy available under the company's SEDAR profile. MustGrow utilizes the mustard seed and the plant’s natural defense mechanism as a pre-plant soil biopesticide in its signature, patented products. In addition to its biopesticides, the company is compiling a science-based suite of biological products and assessing third party product label potential. To view…

Continue Reading

WednesdayJul 10, 2019 9:26 am

NetworkNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Collaborates with Lift & Co. Corp. (TSXV: LIFT) (OTCQB: LFCOF) to Bring Brand-Specific Training to Cannabis Retailers

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc, a leading licensed producer of cannabis, this morning announced a collaboration with Lift & Co. Corp. (TSXV: LIFT) (OTCQB: LFCOF) to support the launch of Lift & Co.’s CannSell retail training program. As Canada’s first branded cannabis educational program, CannSell’s retail certification program encourages the responsible sale of cannabis and is offered in seven provinces and one territory. The rollout of the Organigram-branded module began in June. Among other highlights, the module will provide digital training on the company’s innovative three-tiered growing methodology to budtenders across Canada. “Education…

Continue Reading

TuesdayJul 09, 2019 3:28 pm

NetworkNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Adds National Leader to Scientific Advisory Board

Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company, recently named Dr. Steven Levin, M.D., to its scientific advisory board. An article further discussing the appointment reads, “‘Dr. Levin’s vast experience with novel therapies in the anesthesiology and pain-management field, as well as his strong research interest to improve clinical practice in pain management, will be valuable scientific additions to Endonovo,’ Alan Collier, CEO of Endonovo Therapeutics, said in a news release (http://nnw.fm/PeF8s). ‘As a leader in the field of pain management, Steven will contribute valuable knowledge and expertise as we move our programs forward.’ . . . Levin’s membership in professional…

Continue Reading